Dorothea Nagel

7.1k total citations
86 papers, 3.9k citations indexed

About

Dorothea Nagel is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Dorothea Nagel has authored 86 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 26 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Dorothea Nagel's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Research Studies (12 papers) and Genetic factors in colorectal cancer (9 papers). Dorothea Nagel is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Research Studies (12 papers) and Genetic factors in colorectal cancer (9 papers). Dorothea Nagel collaborates with scholars based in Germany, United States and Austria. Dorothea Nagel's co-authors include P Stieber, Stefan Holdenrieder, D. Seidel, Volker Heinemann, Joachim von Pawel, Andrea Peterfi, Alexander Steinle, Helmut R. Salih, H. Raith and Knut Feldmann and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Cancer Research.

In The Last Decade

Dorothea Nagel

86 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothea Nagel Germany 41 1.2k 1.2k 974 781 605 86 3.9k
Marcella M. Johnson United States 41 1.5k 1.2× 2.9k 2.5× 632 0.6× 557 0.7× 756 1.2× 74 5.4k
Francesco Mauri Italy 45 1.7k 1.4× 2.0k 1.7× 892 0.9× 644 0.8× 863 1.4× 136 6.2k
Ingo Schmidt‐Wolf Germany 20 570 0.5× 2.7k 2.3× 557 0.6× 500 0.6× 831 1.4× 73 3.6k
Michael L. Maitland United States 30 1.6k 1.3× 1.3k 1.1× 690 0.7× 1.2k 1.5× 341 0.6× 94 5.0k
Tsutomu Nobori Japan 46 2.9k 2.3× 2.1k 1.8× 978 1.0× 819 1.0× 825 1.4× 210 7.8k
David W. Cescon Canada 34 1.8k 1.4× 2.9k 2.5× 1.4k 1.4× 1.1k 1.4× 385 0.6× 169 5.6k
P Stieber Germany 49 2.6k 2.1× 3.2k 2.7× 1.8k 1.9× 984 1.3× 958 1.6× 214 7.1k
Antonio M. Ballesta Spain 33 984 0.8× 985 0.8× 256 0.3× 326 0.4× 431 0.7× 101 3.4k
Fritz Wrba Austria 38 1.2k 1.0× 1.6k 1.3× 545 0.6× 390 0.5× 1.3k 2.2× 167 4.7k
Kazuhiro Nouso Japan 39 1.3k 1.0× 1.1k 0.9× 1.1k 1.2× 383 0.5× 819 1.4× 221 5.0k

Countries citing papers authored by Dorothea Nagel

Since Specialization
Citations

This map shows the geographic impact of Dorothea Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothea Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothea Nagel more than expected).

Fields of papers citing papers by Dorothea Nagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothea Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothea Nagel. The network helps show where Dorothea Nagel may publish in the future.

Co-authorship network of co-authors of Dorothea Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothea Nagel. A scholar is included among the top collaborators of Dorothea Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothea Nagel. Dorothea Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagel, Dorothea, Enrico N. De Toni, Alexander Philipp, et al.. (2023). Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients. Cancer Biomarkers. 37(4). 237–248. 3 indexed citations
2.
Winkel, Mark op den, Dorothea Nagel, Jörg Trojan, et al.. (2017). Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score. European Journal of Gastroenterology & Hepatology. 30(1). 44–53. 8 indexed citations
3.
4.
Zander, Johannes, Dorothea Nagel, Christina Scharf, et al.. (2016). Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients. International Journal of Antimicrobial Agents. 48(4). 435–439. 14 indexed citations
5.
Zander, Johannes, Dorothea Nagel, Bárbara Maier, et al.. (2016). Piperacillin concentration in relation to therapeutic range in critically ill patients – a prospective observational study. Critical Care. 20(1). 79–79. 48 indexed citations
6.
Stieber, P, Dorothea Nagel, Volker Heinemann, et al.. (2015). Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients. Clinica Chimica Acta. 448. 228–231. 53 indexed citations
7.
Zöller, Michael, Bárbara Maier, Cyrill Hornuß, et al.. (2014). Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study. Critical Care. 18(4). R148–R148. 91 indexed citations
8.
Philipp, Alexander, Dorothea Nagel, P Stieber, et al.. (2014). Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer. BMC Cancer. 14(1). 245–245. 49 indexed citations
9.
Gioia, Dorit Di, M F Dresse, Doris Mayr, et al.. (2014). Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancer. Clinica Chimica Acta. 440. 16–22. 48 indexed citations
10.
Gioia, Dorit Di, M F Dresse, Doris Mayr, et al.. (2014). Serum HER2 supports HER2-testing in tissue at the time of primary diagnosis of breast cancer. Clinica Chimica Acta. 430. 86–91. 18 indexed citations
11.
Stötzer, Oliver, et al.. (2013). Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy. Clinica Chimica Acta. 425. 206–211. 39 indexed citations
12.
Nagel, Dorothea, et al.. (2013). DNase is a prognostic marker in liver cancer patients receiving transarterial chemoembolization therapy. International Journal of Clinical Pharmacology and Therapeutics. 51(1). 80–83. 2 indexed citations
13.
Nagel, Dorothea, Ralf‐Thorsten Hoffmann, Klaus Tatsch, et al.. (2013). CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing Selective Internal Radiation Therapy. International Journal of Clinical Pharmacology and Therapeutics. 51(1). 63–66. 3 indexed citations
14.
Nagel, Dorothea, Ralf‐Thorsten Hoffmann, Klaus Tatsch, et al.. (2012). Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. International Journal of Cancer. 132(10). 2349–2358. 62 indexed citations
15.
Philipp, Alexander, P Stieber, Dorothea Nagel, et al.. (2012). Prognostic role of methylated free circulating DNA in colorectal cancer. International Journal of Cancer. 131(10). 2308–2319. 87 indexed citations
16.
Fleischhacker, Michael, Bernd Schmidt, Sabine Weickmann, et al.. (2011). Methods for isolation of cell-free plasma DNA strongly affect DNA yield. Clinica Chimica Acta. 412(23-24). 2085–2088. 93 indexed citations
17.
Fraunberger, Peter, Ying Wang, Ernst Holler, et al.. (2006). PROGNOSTIC VALUE OF INTERLEUKIN 6, PROCALCITONIN, AND C-REACTIVE PROTEIN LEVELS IN INTENSIVE CARE UNIT PATIENTS DURING FIRST INCREASE OF FEVER. Shock. 26(1). 10–12. 90 indexed citations
18.
Holdenrieder, Stefan, et al.. (2004). Nucleosomes Indicate the in vitro Radiosensitivity of Irradiated Bronchoepithelial and Lung Cancer Cells. Tumor Biology. 25(5-6). 321–326. 11 indexed citations
19.
20.
Stieber, P, Rafael Molina, Daniel W. Chan, et al.. (2003). Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients.. PubMed. 49(1-2). 15–24. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcella M. Johnson Breakdown of academic impact, for papers by Francesco Mauri Breakdown of academic impact, for papers by Ingo Schmidt‐Wolf Breakdown of academic impact, for papers by Michael L. Maitland Breakdown of academic impact, for papers by Tsutomu Nobori Breakdown of academic impact, for papers by David W. Cescon Breakdown of academic impact, for papers by P Stieber Breakdown of academic impact, for papers by Antonio M. Ballesta Breakdown of academic impact, for papers by Fritz Wrba Breakdown of academic impact, for papers by Kazuhiro Nouso
Rankless by CCL
2026